These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2308056)

  • 1. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Microencapsul; 1990; 7(1):85-94. PubMed ID: 2308056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Pharm Sci; 1989 Sep; 78(9):745-8. PubMed ID: 2585268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
    Gupta PK; Hung CT
    Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats.
    Gupta PK; Hung CT; Rao NS
    J Pharm Sci; 1989 Apr; 78(4):290-4. PubMed ID: 2724092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the anticancer efficacy of doxorubicin carrying microspheres and liposomes using a rat liver tumour model.
    Codde JP; Lumsden AJ; Napoli S; Burton MA; Gray BN
    Anticancer Res; 1993; 13(2):539-43. PubMed ID: 8517669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target distribution of magnetic albumin nanoparticles containing adriamycin in transplanted rat liver cancer model.
    Gong LS; Zhang YD; Liu S
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):365-8. PubMed ID: 15313670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced toxicity of adriamycin by incorporation into ion exchange microspheres: a therapeutic study using a rat liver tumour model.
    Codde JP; Burton MA; Kelleher DK; Archer SG; Gray BN
    Anticancer Res; 1990; 10(6):1715-8. PubMed ID: 2285247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of magnetically responsive albumin microspheres containing cis-hydroxyproline for scar inhibition.
    Iannotti JP; Baradet TC; Tobin M; Alavi A; Staum M
    J Orthop Res; 1991 May; 9(3):432-44. PubMed ID: 2010848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat.
    Gallo JM; Gupta PK; Hung CT; Perrier DG
    J Pharm Sci; 1989 Mar; 78(3):190-4. PubMed ID: 2724075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiment and clinical application of targeting treatment with adriamycin magnetic albumin microspheres in human gastric carcinoma].
    Tao K; Chen D; Wang G; Bai Z; Lu X; Tian Y; Wu Z; Hu F; Nie X
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):205-7. PubMed ID: 11829819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
    Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
    Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers.
    Leakakos T; Ji C; Lawson G; Peterson C; Goodwin S
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):445-50. PubMed ID: 12802508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
    Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW
    J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factorial design based optimization of the formulation of albumin microspheres containing adriamycin.
    Gupta PK; Hung CT; Lam FC
    J Microencapsul; 1989; 6(2):147-60. PubMed ID: 2723957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of targeting efficiency of Adriamycin hydrochloride magnetic microspheres.
    Peng B; Yang X; Li X; Pan H; Zhang Z; Liu H; Ma S; Pan W
    Drug Deliv; 2011 Feb; 18(2):166-72. PubMed ID: 21047168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomedical applications of magnetic fluids. i. Magnetic guidance of ferro-colloid-entrapped albumin microsphere for site specific drug delivery in vivo.
    Morimoto Y; Sugibayashi K; Okumura M; Kato Y
    J Pharmacobiodyn; 1980 May; 3(5):264-7. PubMed ID: 7411389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
    Widder KJ; Morris RM; Poore GA; Howard DP; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):135-9. PubMed ID: 6682771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different dosages of degradable starch microspheres (Spherex) on the distribution of doxorubicin regionally administered to the rat.
    Teder H; Johansson CJ
    Anticancer Res; 1993; 13(6A):2161-4. PubMed ID: 8297129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat.
    Gallo JM; Hung CT; Gupta PK; Perrier DG
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):305-26. PubMed ID: 2810070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
    Widder KJ; Morris RM; Poore G; Howard DP; Senyei AE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):579-81. PubMed ID: 6941258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.